Too many people think alcoholism means just liking booze a little too much. For some, that definitely contributes.
The root causes of alcoholism, according to leading scientists, aren’t that superficial - they start deep in the brain, and emerging research suggests alcoholic tendencies may start years before someone reaches the legal drinking age.
The causes of alcoholism are still under the microscope. But the consequences are clear:
Scientists on the cutting edge of addiction research are exploring every would-be remedy. As of mid-2026, there are ongoing clinical trials looking at applying ultrasound to certain regions of the brain, identifying the roles of specific enzymes, or even testing the utility of GLP-1 drugs.
But what about psilocybin and alcohol? Is that not simply replacing one drug addiction for another? The answer - and the growing body of research on psychedelics as alternative therapies - might surprise you.
According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), alcohol use disorder is “an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences.” AUD is more commonly referred to as alcoholism.
The alcohol use disorders identification test, or AUDIT, has been used as a primary screen for AUD since 1989 and is based on foundational research into the condition. It assigns risk by placing users on a 40-point scale based on their replies to questions about:
Anyone who scores 8/40 or above is recommended to take action related to their drinking habits. Score above a 20 and you’re put into the “severe” category, where alcoholism is both life-disruptive and potentially life-threatening.
Scientists believe conditions like AUD are rooted in neural dysfunction - something amiss in the brain, such as a chemical imbalance, or, more likely, crucial reward circuitry is tangled up, preventing the brain from appropriately managing urges.
AUD sufferers don’t seek alcohol because they find it more palatable than most people. They are, at the neurological level, compelled to do so. Addressing that deep compulsion is the goal of contemporary addiction science. It’s why there's an investigation into psilocybin and alcohol use disorder.
Psilocybin - known colloquially as magic mushrooms - is a classic psychedelic. Beyond making you trip for a few hours, we’ve learned that psilocybin promotes neuroplasticity, which underpins the brain’s ability to rewire maladaptive pathways.
The neuroplastic window is a cornerstone of psychedelic-assisted therapy (PAT), which people seek as a way of escaping mental illness or refreshing their perspective on life. As it turns out, opening the neuroplastic window may help addicts escape their addictions, too.
We’re already seeing promise in rodent studies, where psilocybin seems to enhance “crosstalk” between neurotransmitters and “modulate reward and addiction-related behaviors.” Human research, however, is more complicated.
The regulatory reins around psychedelic research are finally beginning to loosen. Researchers are diving into the therapeutic potential of psychedelics for the treatment of all sorts of afflictions, including but not limited to alcohol use disorder.
So far, the findings are promising but far from conclusive.
There were “robust decreases” in the number of heavy drinking days among 93 alcoholics that persisted for more than six months after undergoing psilocybin-assisted therapy (PAT), according to a 2022 trial.
Psilocybin “durably suppressed” personality traits associated with AUD compared to patients who were given a placebo (diphenhydramine, an allergy medication) during 12 weeks of psychotherapy, per trial data.
“Quantum change” from psychedelic-induced “mystical experiences” may drive AUD sufferers away from the desire to drink, researchers say.
Scientists and institutions are examining the interactions between psilocybin and alcohol from different angles. What do their works have in common? A call for more research.
Initial findings are extremely encouraging. Psilocybin and alcohol seem to be intertwined, and taking psilocybin might help manage alcoholism, according to the few large-scale systematic reviews available. Comprehensive, peer-reviewed evidence is what leads to updated position stands and policy changes.
In the interim, alcoholics and other addicts are turning to both clinical PAT and psychedelic retreats for relief, where teams of facilitators guide guests through psychedelic experiences and help them harness lasting change through proper integration practices.